 NeuroMetrix NASDAQ:NURO shares are trading higher by 153 at 25.41 on continued upward momentum after the company announced that its Quell device has received Breakthrough Designation from the FDA for treating the symptoms of fibromyalgia in adults. NeuroMetrix is a commercial-stage healthcare company. 